These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 31846104)

  • 1. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
    Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
    Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products.
    Hinchliffe P; Calvopiña K; Rabe P; Mojica MF; Schofield CJ; Dmitrienko GI; Bonomo RA; Vila AJ; Spencer J
    J Biol Chem; 2023 May; 299(5):104606. PubMed ID: 36924941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography.
    Spencer J; Read J; Sessions RB; Howell S; Blackburn GM; Gamblin SJ
    J Am Chem Soc; 2005 Oct; 127(41):14439-44. PubMed ID: 16218639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-selective binding of Zn(II) to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.
    Costello A; Periyannan G; Yang KW; Crowder MW; Tierney DL
    J Biol Inorg Chem; 2006 Apr; 11(3):351-8. PubMed ID: 16489411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis.
    Carenbauer AL; Garrity JD; Periyannan G; Yates RB; Crowder MW
    BMC Biochem; 2002; 3():4. PubMed ID: 11876827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faropenem reacts with serine and metallo-β-lactamases to give multiple products.
    Lucic A; Hinchliffe P; Malla TR; Tooke CL; Brem J; Calvopiña K; Lohans CT; Rabe P; McDonough MA; Armistead T; Orville AM; Spencer J; Schofield CJ
    Eur J Med Chem; 2021 Apr; 215():113257. PubMed ID: 33618159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
    Nauton L; Kahn R; Garau G; Hernandez JF; Dideberg O
    J Mol Biol; 2008 Jan; 375(1):257-69. PubMed ID: 17999929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.
    Mojica MF; Rutter JD; Taracila M; Abriata LA; Fouts DE; Papp-Wallace KM; Walsh TJ; LiPuma JJ; Vila AJ; Bonomo RA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266860
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.
    Hinchliffe P; González MM; Mojica MF; González JM; Castillo V; Saiz C; Kosmopoulou M; Tooke CL; Llarrull LI; Mahler G; Bonomo RA; Vila AJ; Spencer J
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3745-54. PubMed ID: 27303030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
    Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal diversity and metallo-beta-lactamase production in clinical isolates of Stenotrophomonas maltophilia.
    Mercuri PS; Ishii Y; Ma L; Rossolini GM; Luzzaro F; Amicosante G; Franceschini N; Frere JM; Galleni M
    Microb Drug Resist; 2002; 8(3):193-200. PubMed ID: 12363008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1).
    Zhang YL; Yang KW; Zhou YJ; LaCuran AE; Oelschlaeger P; Crowder MW
    ChemMedChem; 2014 Nov; 9(11):2445-8. PubMed ID: 25048031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and mechanism of copper- and nickel-substituted analogues of metallo-beta-lactamase L1.
    Hu Z; Spadafora LJ; Hajdin CE; Bennett B; Crowder MW
    Biochemistry; 2009 Apr; 48(13):2981-9. PubMed ID: 19228020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
    Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
    Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal binding Asp-120 in metallo-beta-lactamase L1 from Stenotrophomonas maltophilia plays a crucial role in catalysis.
    Garrity JD; Carenbauer AL; Herron LR; Crowder MW
    J Biol Chem; 2004 Jan; 279(2):920-7. PubMed ID: 14573595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
    Denny BJ; Lambert PA; West PW
    FEMS Microbiol Lett; 2002 Feb; 208(1):21-4. PubMed ID: 11934488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2,4-Triazole-3-thione Compounds as Inhibitors of Dizinc Metallo-β-lactamases.
    Sevaille L; Gavara L; Bebrone C; De Luca F; Nauton L; Achard M; Mercuri P; Tanfoni S; Borgianni L; Guyon C; Lonjon P; Turan-Zitouni G; Dzieciolowski J; Becker K; Bénard L; Condon C; Maillard L; Martinez J; Frère JM; Dideberg O; Galleni M; Docquier JD; Hernandez JF
    ChemMedChem; 2017 Jun; 12(12):972-985. PubMed ID: 28505394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-resolved β-lactam cleavage by L1 metallo-β-lactamase.
    Wilamowski M; Sherrell DA; Kim Y; Lavens A; Henning RW; Lazarski K; Shigemoto A; Endres M; Maltseva N; Babnigg G; Burdette SC; Srajer V; Joachimiak A
    Nat Commun; 2022 Nov; 13(1):7379. PubMed ID: 36450742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo folding of recombinant metallo-beta-lactamase L1 requires the presence of Zn(II).
    Periyannan G; Shaw PJ; Sigdel T; Crowder MW
    Protein Sci; 2004 Aug; 13(8):2236-43. PubMed ID: 15238636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monomeric L1 metallo-beta -lactamase and the role of the N-terminal extension in negative cooperativity and antibiotic hydrolysis.
    Simm AM; Higgins CS; Carenbauer AL; Crowder MW; Bateson JH; Bennett PM; Clarke AR; Halford SE; Walsh TR
    J Biol Chem; 2002 Jul; 277(27):24744-52. PubMed ID: 11940588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.